Cargando…
Emergence and control of infectious diseases in China
Infectious diseases remain the major causes of morbidity and mortality in China despite substantial progress in their control. China is a major contributor to the worldwide infectious disease burden because of its population size. The association of China with the rest of the world through travel an...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138027/ https://www.ncbi.nlm.nih.gov/pubmed/18930534 http://dx.doi.org/10.1016/S0140-6736(08)61365-3 |
_version_ | 1783518524743876608 |
---|---|
author | Wang, Longde Wang, Yu Jin, Shuigao Wu, Zunyou Chin, Daniel P Koplan, Jeffrey P Wilson, Mary Elizabeth |
author_facet | Wang, Longde Wang, Yu Jin, Shuigao Wu, Zunyou Chin, Daniel P Koplan, Jeffrey P Wilson, Mary Elizabeth |
author_sort | Wang, Longde |
collection | PubMed |
description | Infectious diseases remain the major causes of morbidity and mortality in China despite substantial progress in their control. China is a major contributor to the worldwide infectious disease burden because of its population size. The association of China with the rest of the world through travel and trade means that events in the country can affect distant populations. The ecological interaction of people with animals in China favours the emergence of new microbial threats. The public-health system has to be prepared to deal with the challenges of newly emerging infectious diseases and at the same time try to control existing diseases. To address the microbial threats, such as severe acute respiratory syndrome, the government has committed substantial resources to the implementation of new strategies, including the development of a real-time monitoring system as part of the infectious-disease surveillance. This strategy can serve as a model for worldwide surveillance and response to threats from infectious diseases. |
format | Online Article Text |
id | pubmed-7138027 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71380272020-04-07 Emergence and control of infectious diseases in China Wang, Longde Wang, Yu Jin, Shuigao Wu, Zunyou Chin, Daniel P Koplan, Jeffrey P Wilson, Mary Elizabeth Lancet Article Infectious diseases remain the major causes of morbidity and mortality in China despite substantial progress in their control. China is a major contributor to the worldwide infectious disease burden because of its population size. The association of China with the rest of the world through travel and trade means that events in the country can affect distant populations. The ecological interaction of people with animals in China favours the emergence of new microbial threats. The public-health system has to be prepared to deal with the challenges of newly emerging infectious diseases and at the same time try to control existing diseases. To address the microbial threats, such as severe acute respiratory syndrome, the government has committed substantial resources to the implementation of new strategies, including the development of a real-time monitoring system as part of the infectious-disease surveillance. This strategy can serve as a model for worldwide surveillance and response to threats from infectious diseases. Elsevier Ltd. 2008 2008-10-17 /pmc/articles/PMC7138027/ /pubmed/18930534 http://dx.doi.org/10.1016/S0140-6736(08)61365-3 Text en Copyright © 2008 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Wang, Longde Wang, Yu Jin, Shuigao Wu, Zunyou Chin, Daniel P Koplan, Jeffrey P Wilson, Mary Elizabeth Emergence and control of infectious diseases in China |
title | Emergence and control of infectious diseases in China |
title_full | Emergence and control of infectious diseases in China |
title_fullStr | Emergence and control of infectious diseases in China |
title_full_unstemmed | Emergence and control of infectious diseases in China |
title_short | Emergence and control of infectious diseases in China |
title_sort | emergence and control of infectious diseases in china |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138027/ https://www.ncbi.nlm.nih.gov/pubmed/18930534 http://dx.doi.org/10.1016/S0140-6736(08)61365-3 |
work_keys_str_mv | AT wanglongde emergenceandcontrolofinfectiousdiseasesinchina AT wangyu emergenceandcontrolofinfectiousdiseasesinchina AT jinshuigao emergenceandcontrolofinfectiousdiseasesinchina AT wuzunyou emergenceandcontrolofinfectiousdiseasesinchina AT chindanielp emergenceandcontrolofinfectiousdiseasesinchina AT koplanjeffreyp emergenceandcontrolofinfectiousdiseasesinchina AT wilsonmaryelizabeth emergenceandcontrolofinfectiousdiseasesinchina |